192 related articles for article (PubMed ID: 1673033)
1. Induction of transforming growth factor beta 1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins.
Missero C; Filvaroff E; Dotto GP
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3489-93. PubMed ID: 1673033
[TBL] [Abstract][Full Text] [Related]
2. Counteracting effects of E1a transformation on cAMP growth inhibition.
Florin-Christensen M; Missero C; Florin-Christensen J; Tranque P; Ramon y Cajal S; Dotto GP
Exp Cell Res; 1993 Jul; 207(1):57-61. PubMed ID: 8391467
[TBL] [Abstract][Full Text] [Related]
3. Skin-specific expression of a truncated E1a oncoprotein binding to p105-Rb leads to abnormal hair follicle maturation without increased epidermal proliferation.
Missero C; Serra C; Stenn K; Dotto GP
J Cell Biol; 1993 Jun; 121(5):1109-20. PubMed ID: 7684738
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1 (TGF beta 1) reduces cellular levels of p34cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity.
Abraham SE; Carter MC; Moran E
Mol Biol Cell; 1992 Jun; 3(6):655-65. PubMed ID: 1323350
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of E1A-induced transforming growth factor-beta (TGF-beta) resistance in mouse keratinocytes involves repression of TGF-beta type II receptor transcription.
Kim DH; Chang JH; Lee KH; Lee HY; Kim SJ
J Biol Chem; 1997 Jan; 272(1):688-94. PubMed ID: 8995313
[TBL] [Abstract][Full Text] [Related]
6. Independent transformation activity by adenovirus-5 E1A-conserved regions 1 or 2 mutants.
Svensson C; Bondesson M; Nyberg E; Linder S; Jones N; Akusjärvi G
Virology; 1991 Jun; 182(2):553-61. PubMed ID: 1827227
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
[TBL] [Abstract][Full Text] [Related]
8. The E1a gene prevents inhibition of keratinocyte proliferation by dexamethasone.
Florin-Christensen M; Missero C; Dotto GP; Florin-Christensen J
Exp Cell Res; 1992 Nov; 203(1):285-8. PubMed ID: 1426049
[TBL] [Abstract][Full Text] [Related]
9. Escape from transforming growth factor beta control and oncogene cooperation in skin tumor development.
Missero C; Ramon y Cajal S; Dotto GP
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9613-7. PubMed ID: 1946376
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1-mediated induction of junB is selectively inhibited by expression of Ad.12-E1A.
Coussens LM; Yokoyama K; Chiu R
J Cell Physiol; 1994 Sep; 160(3):435-44. PubMed ID: 8077281
[TBL] [Abstract][Full Text] [Related]
11. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis.
Howe JA; Mymryk JS; Egan C; Branton PE; Bayley ST
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5883-7. PubMed ID: 2143024
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus E1A antagonizes both negative and positive growth signals elicited by transforming growth factor beta 1.
de Groot RP; Kranenburg O; de Wit L; van den Eijnden-van Raaij J; Mummery C; van der Eb AJ; Zantema A
Cell Growth Differ; 1995 May; 6(5):531-40. PubMed ID: 7647036
[TBL] [Abstract][Full Text] [Related]
14. Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes.
Game SM; Huelsen A; Patel V; Donnelly M; Yeudall WA; Stone A; Fusenig NE; Prime SS
Int J Cancer; 1992 Sep; 52(3):461-70. PubMed ID: 1328069
[TBL] [Abstract][Full Text] [Related]
15. Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product.
Giordano A; McCall C; Whyte P; Franza BR
Oncogene; 1991 Mar; 6(3):481-5. PubMed ID: 1826347
[TBL] [Abstract][Full Text] [Related]
16. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
Zhao J; Buick RN
Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.
Pietenpol JA; Stein RW; Moran E; Yaciuk P; Schlegel R; Lyons RM; Pittelkow MR; Münger K; Howley PM; Moses HL
Cell; 1990 Jun; 61(5):777-85. PubMed ID: 2140528
[TBL] [Abstract][Full Text] [Related]
18. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
[TBL] [Abstract][Full Text] [Related]
19. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
20. Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A.
Howe JA; Bayley ST
Virology; 1992 Jan; 186(1):15-24. PubMed ID: 1530776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
